Author

Elsebet Eriksen

OpenAlex ID: A5010580944

Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients

2022 · Nicolas M. Van Mieghem, G. Michael Deeb, et al. · JAMA Cardiology · 194

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

2025 · Javed Butler, Ciaran J McMullan, et al. · The Lancet · 94

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

2025 · Faiez Zannad, Christopher M O'Connor, et al. · The Lancet · 53

The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial

2026 · Francesco Fioretti, Faiez Zannad, et al. · European Journal of Heart Failure · 1

Works count: 4

Citation count: 340

H-index: 3

I10-index: 3